Search research articles
Contact Us
Filters
Showing results (11-20 of 42) with videos related to
Page
of 5
Sort By:
Journal of Clinical Pathology
|
March 27, 2012
Comparison of the RNA-based EndoPredict multigene test between core biopsies and corresponding surgical breast cancer sections
Berit Maria Müller, Jan C Brase, Franziska Haufe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 8, 2010
ERBB2 and TOP2A in breast cancer: a comprehensive analysis of gene amplification, RNA levels, and protein expression and their influence on prognosis and prediction
Jan C Brase, Marcus Schmidt, Thomas Fischbach, et al.
Plos One
|
April 5, 2013
ERG induces epigenetic activation of Tudor domain-containing protein 1 (TDRD1) in ERG rearrangement-positive prostate cancer
Lukasz A Kacprzyk, Mark Laible, Tatjana Andrasiuk, et al.
International Journal of Molecular Sciences
|
March 6, 2013
A Cancer-Indicative microRNA Pattern in Normal Prostate Tissue
Olaf J C Hellwinkel, Christina Sellier, Yu-Mi Jessica Sylvester, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
September 5, 2012
The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer
Ruprecht Kuner, Maria Fälth, Nicole Chui Pressinotti, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 16, 2013
Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients
Sajo Kaduthanam, Stephan Gade, Michael Meister, et al.
Virchows Archiv : an International Journal of Pathology
|
September 15, 2014
Preanalytical variables and performance of diagnostic RNA-based gene expression analysis in breast cancer
Christopher Poremba, Jennifer Uhlendorff, Berit M Pfitzner, et al.
Pharmacoeconomics
|
November 19, 2014
Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients
Patricia R Blank, Martin Filipits, Peter Dubsky, et al.
Journal for Immunotherapy of Cancer
|
June 21, 2022
Spartalizumab or placebo in combination with dabrafenib and trametinib in patients with <i>BRAF</i> V600-mutant melanoma: exploratory biomarker analyses from a randomized phase 3 trial (COMBI-i)
Hussein A Tawbi, Caroline Robert, Jan C Brase, et al.
BMC Cancer
|
December 7, 2011
TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling
Jan C Brase, Marc Johannes, Heiko Mannsperger, et al.
Page
of 5
Search research articles
Search
Showing results (11-20 of 42) with videos related to
Sort By:
Page
of 5
Journal of Clinical Pathology
|
March 27, 2012
Comparison of the RNA-based EndoPredict multigene test between core biopsies and corresponding surgical breast cancer sections
Berit Maria Müller, Jan C Brase, Franziska Haufe, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
April 8, 2010
ERBB2 and TOP2A in breast cancer: a comprehensive analysis of gene amplification, RNA levels, and protein expression and their influence on prognosis and prediction
Jan C Brase, Marcus Schmidt, Thomas Fischbach, et al.
Plos One
|
April 5, 2013
ERG induces epigenetic activation of Tudor domain-containing protein 1 (TDRD1) in ERG rearrangement-positive prostate cancer
Lukasz A Kacprzyk, Mark Laible, Tatjana Andrasiuk, et al.
International Journal of Molecular Sciences
|
March 6, 2013
A Cancer-Indicative microRNA Pattern in Normal Prostate Tissue
Olaf J C Hellwinkel, Christina Sellier, Yu-Mi Jessica Sylvester, et al.
Journal of Molecular Medicine (Berlin, Germany)
|
September 5, 2012
The maternal embryonic leucine zipper kinase (MELK) is upregulated in high-grade prostate cancer
Ruprecht Kuner, Maria Fälth, Nicole Chui Pressinotti, et al.
Lung Cancer (Amsterdam, Netherlands)
|
February 16, 2013
Serum miR-142-3p is associated with early relapse in operable lung adenocarcinoma patients
Sajo Kaduthanam, Stephan Gade, Michael Meister, et al.
Virchows Archiv : an International Journal of Pathology
|
September 15, 2014
Preanalytical variables and performance of diagnostic RNA-based gene expression analysis in breast cancer
Christopher Poremba, Jennifer Uhlendorff, Berit M Pfitzner, et al.
Pharmacoeconomics
|
November 19, 2014
Cost-effectiveness analysis of prognostic gene expression signature-based stratification of early breast cancer patients
Patricia R Blank, Martin Filipits, Peter Dubsky, et al.
Journal for Immunotherapy of Cancer
|
June 21, 2022
Spartalizumab or placebo in combination with dabrafenib and trametinib in patients with <i>BRAF</i> V600-mutant melanoma: exploratory biomarker analyses from a randomized phase 3 trial (COMBI-i)
Hussein A Tawbi, Caroline Robert, Jan C Brase, et al.
BMC Cancer
|
December 7, 2011
TMPRSS2-ERG -specific transcriptional modulation is associated with prostate cancer biomarkers and TGF-β signaling
Jan C Brase, Marc Johannes, Heiko Mannsperger, et al.
Page
of 5